249 research outputs found

    なにわ伝統野菜のもつ今日的意義 : なにわの伝統野菜で大阪を「しんか」させよう

    Get PDF
    第2回NOCHSレクチャーシリーズ「なにわ伝統野菜V.S.京野菜 -復興のなにわか・伝統の京か-」(関西大学図書館ホール、2006年1月14日)補助事業 文部科学省私立大学学術研究高度化推進事業オープン・リサーチ・センター整備事業(平成17年度~平成21年度)なにわ・大阪文化遺産の総合人文学的研

    ベトナム国におけるサトイモ遺伝資源の共同探索収集

    Get PDF
    We explored for taro (Colocasia esculenta Shott.) germplasm in the northwest region of Vietnam from November 29 to December 28, 1994. This area is thought to be important for the genetic diversity of C. esculenta. The itinerary and the exploration route are shown (Table 1. and Fig. 1.), respectively. We collected a total of 56 corm samples, of which 2 were cultured for pig fodder. These taros varied in corm size and shape, corm color, bud color and petiole color etc. Most of the collection was edoe type, but some of them may be belong to dasheen type

    PRIMARY MALIGNANT LYMPHOMA OF THE BREAST : A CASE REPORT

    Get PDF
    A case of primary malignant lymphoma of the breast is reported. A 61-year-old woman visited the hospital because of tumor in the upper outer quadrant of the right breast. Palpation, an ultrasonography and mammography suggested breast cancer. Needle aspiration biopsy of the mass yielded tumor cells, so a standard radical mastectomy was performed. The pathological specimen revealed malignant lymphoma, diffused type, medium sized cell, B cell type on LSG classification. Postoperative examination disclosed no abnormal findings and so it was diagnosed as primary malignant lymphoma of the breast

    A CASE OF PYRUVATE KINASE DEFICIENCY ASSOCIATED WITH ACUTE MONOCYTIC LEUKEMIA

    Get PDF
    A case of pyruvate kinase deficiency anemia associated with acute monocytic leukemia is reported with a review of the literature. A 57-year-old man who was treated for diabetes mellitus at a nearby hospital was admitted to our hospital for precise examination of the progression of anemia. Blood examination showed RBC 207×10⁴/μl, Hb 5.9 g/dl, Ht 18%, reticulocytes 134‰, WBC 5,200/μl, platelets 9.3×10⁴/μl, indirect bilirubin 0.6 mg/dl, serum iron 112 μg/dl, haptoglobin under 10 μg/dl. After admission to our hospital, serum indirect bilirubin level was increased to 2.3 mg/dl, and pancytopenia was noted in the peripheral blood. the half life span of erythrocytes had shortened to 16 days. A bone marrow examination revealed prominent erythroid hyperplasia. More detailed examination of this hemolysis revealed pyruvate kinase deficiency of erythrocytes. Three months after admission, blast cells were noted in the peripheral blood and they increased progressively. The bone marrow contained 43.6% of blast cells. Subsequently, a diagnosis of acute monocytic leukemia was made. Although intensive chemotherapy was performed, the patient achieved no remission and died 6 months after admission to our hospital

    Clinical studies on tosufloxacin (TFLX) in urology

    Get PDF
    横浜市立大学泌尿器科およびその関連施設を加えた13施設で, TFLXを使用して有効性と安全性について検討した.1)女子急性単純性膀胱炎164例の総合有効率は98.78%であった.2)男子急性単純性膀胱炎4例, 急性単純性腎盂腎炎3例, 非淋菌性尿道炎1例, 複雑性尿路感染症7例にも投与して100%の有効率がえられた.3)原因菌の中で, グラム陰性菌は100%の消失率で, グラム陽性菌は90.60%の消失率であった.4)副作用発現は5例にみられ, その発現率は2.42%であったWe clinically evaluated the usefulness of a new oral antimicrobial agent, TFLX, in the field of urology. The dose administered was 150 mg t.i.d and the duration of administration was 3 days. The clinical effect was evaluated according to the criteria of the Japanese UTI committee. The clinical response obtained on 164 female patients with acute simple cystitis was excellent in 118, moderate in 44 and poor in 2 patients. The efficacy rate was 98.78%. The clinical response obtained on 4 male patients with acute simple cystitis was excellent in 2 and moderate in 2 patients. The efficacy rate was 100%. The clinical response obtained on 3 female patients with simple pyelonephritis was excellent in 2 and moderate in 1 patient. The efficacy rate was 100%. The clinical response obtained on one patient with non-gonococcal urethritis was excellent by doctor's evaluation. The clinical response obtained on 7 patients with complicated UTI was excellent in 3 and moderate in 4 patients. The efficacy rate was 100%. Three patients complained of stomach distress or malaise and 2 patients developed rash. No abnormal laboratory data were observed. Thus, TFLX appears to be safe and suitable for use in the field of urology
    corecore